A study on androgen receptor (AR) overexpression increased blood metastasis but reduced LMs showed that there was also a gender difference between lung metastasis and lymph node metastasis in RCC patients. The gene discussed is AR; the disease is metastatic malignant neoplasm in the lymph nodes.